Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma

NCT02916420 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.